Effects of Acetaldehyde on the Isolated Papillary Muscle of Diabetic Rats

Adedapo O. Savage, Joseph C. Dunbar, Ricardo A. Brown

Journal of Cardiovascular Pharmacology · 1995 · 19 citations · 0 references

Concepts

Abstract

The effects of acetaldehyde (ACA) were examined in isolated electrically driven papillary muscle preparations from normal and streptozotocin-treated diabetic rats. Muscles from diabetic rats developed greater tension than those from normal rats. In muscles from both groups, ACA caused concentration-dependent negative inotropic effects that were independent of cholinergic or purinergic mechanisms and were not attributable to nitric oxide (NO) release. ACA was three to five times more potent with regard to its negative inotropic effect in diabetic than in normal rat muscles. A propranololsensitive, sympathetically mediated positive inotropic effect occurred at certain concentrations. Decreasing [Ca2+ ]0 from 2.7 to 0.5 mM reduced basal developed force to a significantly greater extent in muscles from normal rats than in those from diabetic rats. In low [Ca2+ ]0, concentration-response curves to CaCl2 in diabetic muscles were displaced to the left of that in normal muscles, suggesting that diabetic muscles are more sensitive to the positive inotropic effect of added CaCl2 at low [Ca2+ ]0, whereas at higher [Ca2+ ]0 (>1 mM), normal muscles developed more force in response to added CaCl2. ACA 10 and 30 mM more readily inhibited CaCl2-induced positive inotropic effect in normal than in diabetic muscles. Force-frequency curves, (negative staircase response) were recorded in both normal and diabetic muscles. In diabetic muscles, the curve exhibited a positive component at the lowest frequencies applied and was displaced to the right of that in normal muscle. ACA concentration-dependently inhibited force development, and diabetic muscles were more susceptible to the negative inotropic effect of ACA, when the stimulation frequency was increased. Ouabain 30 μM induced a positive inotropic effect of 21% in normal rat muscles, but increased basal developed force by 7% in diabetic preparations (p < 0.01). The magnitude of the negative inotropic effect of ACA with or without ouabain were similar in papillary muscles from both groups. In the diabetic myocardium, in which resting intracellular Ca2+ levels reportedly are increased, the negative inotropic effect of ACA is attenuated by increasing the [Ca2+ ]0, but not by increasing the [Ca2+ ]i with ouabain. The mechanism(s) involved in the negative inotropic effect of ACA are intimately related to the intracellular Ca2+ levels, which may not be identical in normal and diabetic myocardium, and that ACA reduces contractility by preventing the release of activator Ca2+.